Linden Thomas Advisory Services, LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1965702
Charlotte, NC
Position in KNSA
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,504,651
-$2,358,911 QoQ
Shares Held
54,803
-55.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#73
of 264 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Linden Thomas Advisory Services, LLC holds $9,701,809 across 5 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (36.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
54,803 | $3,504,651 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
18,676 | $3,147,653 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
19,695 | $2,184,963 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
26,385 | $649,334 | |
| 5 | PRGO |
PERRIGO Co plc
|
20,713 | $215,208 |
All Filings in KNSA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,504,651 | 54,803 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $5,863,562 | 121,777 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $4,721,557 | 114,462 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $4,505,833 | 116,040 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,212,902 | 116,115 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,604,811 | 117,281 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,326,207 | 117,604 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $2,941,572 | 117,710 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,208,698 | 118,302 | Shares | Sole | 2024-07-10 | |
| No filing history on record for this holder in this stock. | ||||||